Antisense Gene Therapy Using Anti-K-Ras and Antitelomerase Oligonucleotides in Colorectal Cancer

Revista Espanola de Enfermedades Digestivas - Spain
doi 10.4321/s1130-01082005000700002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Instituto de Salud Carlos III/BNCS/SciELO Espana

Related search

K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

P53 Expression and K-Ras Mutation in Colorectal Adenomas.

Gut
Gastroenterology
1993English

Hydrogen Peroxide-Triggered Gene Silencing in Mammalian Cells Through Boronated Antisense Oligonucleotides

Chemical Science
Chemistry
2018English

Tetrac and NDAT Induce Anti-Proliferation via Integrin Αvβ3 in Colorectal Cancers With Different K-Ras Status

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

RAS and BRAF in Metastatic Colorectal Cancer Management

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2016English

Tumor Protein P53 and K-Ras Gene Mutations in Peruvian Patients With Gallbladder Cancer

Asian Pacific Journal of Cancer Prevention
2019English

Tumor Metastasis‐associated Human MTA1 Gene: Its Deduced Protein Sequence, Localization, and Association With Breast Cancer Cell Proliferation Using Antisense Phosphorothioate Oligonucleotides

Journal of Cellular Biochemistry
BiochemistryCell BiologyMolecular Biology
2000English

The Presence of Mutations in the K-Ras Gene Does Not Affect Survival After Resection of Pulmonary Metastases From Colorectal Cancer

ISRN Surgery
2014English

Antisense Gene Therapy for Neurodegenerative Disease?

Experimental Neurology
Developmental NeuroscienceNeurology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy